Company intelligence / Profile preview

UpWest

Palo Alto, California, United States

Ownership: Private
Employees: ~27
Development stage: Other

Overview

UpWest is an active seed-stage venture capital firm rather than a biotechnology, pharmaceutical, or healthcare operating company. The firm focuses on backing Israeli entrepreneurs targeting the U.S. market and has invested across multiple technology sectors, including some healthcare and biotech-related portfolio companies. Available public information describes UpWest as an investor based in Palo Alto with an Israel-focused cross-border venture strategy. Because UpWest is an investment firm and not a therapeutic developer, it does not appear to have its own drug pipeline, clinical programs, modalities, or targets.

Industry: Investors

Beyond the preview

Go deeper on UpWest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UpWest.

Explore the full profile